Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.12B
Enterprise Value6.67B
P/E Ratio208.21
PEG Ratio0.58
Price/Sales Ratio1.71
Price/Book Ratio1.64
Enterprise/Revenue2.82
Enterprise/EBITDA25.97

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0
Return On Equity0.01

Income Statement

Revenue2.45B
Revenue/Share5.64
Gross Profit449.9M
EBITDA341.04M
Net Income10.23M
Diluted EPS0.02

Balance Sheet

Total Cash308.01M
Total Cash/Share0.7
Total Debt3.04B
Total Debt/Equity1.18
Current Ratio1.02
Book Value Per Share5.89

Price History

52-Week Change-6.32
52-Week High14.37
52-Week Low8.97
Moving Average 50 Days10.8
Moving Average 200 Days10.52

Statistics

Average Volume29.29M
Shares Outstanding438.41M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield3.11
Payout Ratio6.44
Last Split Factor7:5
Last Split DateJune 17, 2022
AD